Skip to search formSkip to main contentSkip to account menu

imirestat

Known as: 2,7-Difluorospiro(fluorene-9,4'-imidazolidine)-2',5'-dione, spiro(2,7-difluoro-9H-fluoren-9,4'-imidazolidine)-2',5'-dione 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

AL 1576HOE 843

Broader (2)

FluorenesHydantoins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Application of 19F-n.m.r. spectroscopy to the identification of dog urinary metabolites of imirestat, a spirohydantoin aldose reductase inhibitor.
1. Urine from a dog dosed orally at 20 mg/kg with 14C-imirestat, a spirohydantoin aldose reductase inhibitor, contained 17.7 and… 
1992
1992
Studies on the biochemical effects of the aldose reductase inhibitor 2,7-difluorospirofluorene-9,5'-imidazolidine-2',4'-dione (Al 1576, HOE 843). Detection of D-glucaric and D-glucuronic acid…
1991
1991
Capillary gas chromatographic-electron-capture assay for the aldose reductase inhibitor imirestat in lens and plasma.
1989
1989
Effect of protein binding on the high-performance liquid chromatography of phenytoin and imirestat in human serum by direct injection onto internal surface reversed-phase columns.
Internal surface reversed-phase (ISRP) columns have been designed to facilitate the HPLC analysis of drugs in blood serum or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)